Corecam Pte Ltd’s Pfizer PFE Stock Holding History

Corecam Pte Ltd’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.77M	Buy	322,630 +26,700	+9%	+$698K	2.94%	12
2026 Q1	$8.31M	Buy	295,930 +6,300	+2%	+$168K	3.6%	10
2025 Q4	$7.21M	Buy	289,630 +7,900	+3%	+$199K	3.75%	10
2025 Q3	$7.18M	Buy	281,730 +10,530	+4%	+$260K	3.75%	9
2025 Q2	$6.57M	Sell	271,200 -6,700	-2%	-$156K	3.68%	12
2025 Q1	$7.04M	Buy	277,900 +1,300	+0.5%	+$34K	3.82%	10
2024 Q4	$7.34M	Buy	276,600 +32,700	+13%	+$887K	3.97%	9
2024 Q3	$7.06M	Buy	243,900 +59,600	+32%	+$1.74M	4.6%	8
2024 Q2	$5.16M	Buy	184,300 +44,700	+32%	+$1.23M	3.84%	12
2024 Q1	$3.87M	Buy	139,600 +53,700	+63%	+$1.49M	3.56%	14
2023 Q4	$2.47M	Buy	+85,900	New	+$2.6M	2.66%	12

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Corecam Pte Ltd's PFE Position: Q2 2026 in Review

Corecam Pte Ltd increased its Pfizer (PFE) stake by 9% in Q2 2026, buying an estimated $698K and bringing the position to 322,630 shares worth $7.77M. The position accounts for 2.94% of the portfolio, ranked #12.

Corecam Pte Ltd first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $8.31M in Q1 2026. 2,366 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Corecam Pte Ltd held 322,630 shares of Pfizer worth $7.77M as of Q2 2026.
Corecam Pte Ltd bought 26,700 Pfizer shares in Q2 2026, an estimated $698K.
Pfizer made up 2.94% of Corecam Pte Ltd's portfolio in Q2 2026, its #12 holding.
Corecam Pte Ltd first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
Corecam Pte Ltd's Pfizer position peaked at $8.31M in Q1 2026.
2,366 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Corecam Pte Ltd's 13F filing for Q2 2026, filed 14 Jul 2026.